The HealthTree Foundation for Multiple Myeloma is proud to host a PEERView session at the upcoming ASCO conference with the topic The "Myelennial" Generation - Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes. The session will feature myeloma experts Nina Shah, MD, Shaji Kumar, MD and Sagar Lonial, MD.
- Saturday, June 4
- 7:00 - 8:30 pm Central
Key Reasons to Attend
- Explore recent changes in therapy selection for newly diagnosed MM, including antibody and triplet therapy options, and guideline recommendations for upfront treatment of ASCT-ineligible and -eligible disease
- Hear the evidence that supports CD38 antibodies, XPO1 inhibitors, and BCMA-targeting options in RRMM
- Understand how to manage the unique AEs associated with BCMA ADCs, CAR-T therapy, and bispecific agents, such as keratopathy/ocular toxicity, CRS, ICANS, and peripheral neuropathy
This activity has been developed in partnership with HealthTree Foundation for Multiple Myeloma.
Meet Your Presenters
Chair & Presenter
Nina Shah, MD
UCSF Helen Diller Family Comprehensive Cancer Center
The University of California, San Francisco
San Francisco, California
Shaji K. Kumar, MD
Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
The Live meeting will be Hyatt Regency Chicago, Grand Ballroom AB, Ballroom Level (East Tower), 151 East Wacker Drive, Chicago, Illinois 60601
about the author
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of HealthTree Foundation (formerly Myeloma Crowd).